Published February 13, 2026
| Version v1
Poster
Open
Development of an antisens oligonucleotide therapy for oculopharyngeal muscular dystrophy using iPSC-derived myocytes
Authors/Creators
- 1. Department of medicine, Faculty of medecine, Université Laval, Québec, QC, Canada
- 2. Neuroscience Research program, CHU de Québec-Université Laval Research center, Québec, QC, Canada
- 3. Université Laval's Research Centre: The Tissue Engineering Laboratory (LOEX), Québec, QC, Canada
Files
Poster_DEVELOPMENT OF AN ANTISENSE OLIGONUCLEOTIDE THERAPY FOR OCULOPHARYNGEAL MUSCULAR DYSTROPHY USING iPSC-DERIVED MYOCYTES(48 x 36 po)_20251006.pdf
Files
(11.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:c3cb6f9f9e58cd689be6e533ea312646
|
11.4 MB | Preview Download |